4 completed, 3 recruiting, 2 unknown, 1 enrolling by invitation. 4 Not applicable, 3 Phase 2, 2 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 1, Enrolling by invitation 1, Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 2 | Recruiting 2 |
| Phase 4 | 1 | Unknown 1 |
Follow Head and Neck: new trials by email Literature Review of Head and Neck trials Research Report on Head and Neck
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SPECT-CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal Cancer Lymphatic mapping with SPECT-CT, Bilateral neck radiotherapy, Ipsilateral neck radiotherapy & SPECT-CT guided contralateral neck radiotherapy - Oropharyngeal Squamous Cell Carcinoma, Oropharyngeal Cancers | Not applicable | Not yet recruiting | UNICANCER | 128 | 2026-09-01 | 2026-07-21 |
| Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC) Nivo800, Nivolumab - Hnscc, Head and Neck | Phase 1 | Recruiting | Vanderbilt-Ingram Cancer Center | 40 | 2026-07-03 | 2026-10-16 |
| A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC EPI-326 - Epidermal Growth Factor, Epidermal Growth Factor Receptor | Phase 1 | Recruiting | EpiBiologics | 110 | 2026-03-31 | 2026-10-14 |
| 4DryField PH and Head and Neck Operations. Polysaccharide based hemostat (4DryField PH) - Head and Neck | Not applicable | Enrolling by invitation | Taichung Veterans General Hospital | 60 | 2026-01-01 | 2026-03-25 |
| Immediate Neuromuscular Responses of the Obliquus Capitis Inferior Following Upper Cervical Manual Therapy Thrust long-axis manipulation of C1-C2 - Head and Neck, Headache | Not applicable | Recruiting | Florida Gulf Coast University | 80 | 2025-05-01 | 2026-08-28 |
| Identification of Nerves Using Fluorescein Sodium Fluorescein Sodium - Pleomorphic Adenoma of the Parotid, Warthin Tumor | Phase 2 | Completed | Stanford University | 8 | 2024-11-07 | 2026-05-20 |
| Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer Avmacol - Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC) | Not applicable | Completed | University of Pittsburgh | 6 | 2018-07-27 | 2023-04-07 |
| Value of Geriatric Screening to Predict Postoperative Morbidity for Head and Neck Cancer Head and Neck | Unknown | AZ Sint-Jan AV | 94 | 2017-01-25 | 2024-08-09 | |
| The Use of Prostaglandin E1 in Head and Neck Microsurgery Prostaglandin E1, Saline - Microsurgery, Head and Neck | Phase 4 | Unknown | National Taiwan University Hospital | 242 | 2008-07-01 | 2009-10-27 |
| Cetuximab at Either 500 or 750 mg/m2 Every Other Week for Recurrent or Metastatic Head and Neck Squamous Cell Cancer cetuximab - Head and Neck, Squamous Cell Cancer | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 61 | 2007-11-01 | 2018-01-11 |
| A Multicenter Study of Intensive Concomitant Chemoradiotherapy With Filgrastim (GCSF) for Patients With Locoregionally Advanced Head and Neck Cancer Hydroxyurea, 5- Fluorouracil, Cisplatin - Head and Neck | Phase 2 | Completed | University of Chicago | 44 | 2003-03-01 | 2024-01-29 |
Head and Neck Neoplasms (5) · Squamous Cell Carcinoma of Head and Neck (4) · Neoplasms, Squamous Cell (2) · Adenolymphoma (1) · Carcinoma in Situ (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Squamous Cell (1) · Headache (1) · Hyperplasia (1) · Laryngeal Diseases (1) · Mouth Neoplasms (1) · Neoplasms (1) · Oropharyngeal Neoplasms (1) · Thrombosis (1) · Thyroid Diseases (1)
Neoplasms (6) · Neoplasms by Histologic Type (6) · Neoplasms by Site (5) · Neoplasms, Glandular and Epithelial (5) · Carcinoma (4) · Carcinoma, Squamous Cell (3) · Otorhinolaryngologic Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Respiratory Tract Diseases (2) · Stomatognathic Diseases (2) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Cardiovascular Diseases (1) · Embolism and Thrombosis (1) · Endocrine System Diseases (1)
Alprostadil (1) · Cetuximab (1) · Cisplatin (1) · Fluorescein (1) · Fluorouracil (1) · Hydroxyurea (1) · Nivolumab (1) · Saline Solution (1) · Sodium Chloride (1)
AZ Sint-Jan AV (1) · EpiBiologics (1) · Florida Gulf Coast University (1) · Memorial Sloan Kettering Cancer Center (1) · National Taiwan University Hospital (1) · Stanford University (1) · Taichung Veterans General Hospital (1) · UNICANCER (1) · University of Chicago (1) · University of Pittsburgh (1) · Vanderbilt-Ingram Cancer Center (1)
United States (7) · Taiwan (3) · Belgium (1) · France (1) · South Korea (1)
Dan P Zandberg, MD (1) · Eben Rosenthal, MD (1) · Everett Vokes, MD (1) · Johan Abeloos, MD (1) · Matthew Fury, MD,PhD (1) · Tulio Valdez, MD (1) · Yueh-Bih Tang, MD, PhD (1)
R25DC020174 (1)